BlackRock »

Cerevel Therapeutics Hldng I shares owned by BlackRock

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by BlackRock

Quarter filed Position value Share count Share price at filing
2024-06-30 $146M 3.6M 40.89
2024-03-31 $230M 5.4M 42.27
2023-09-30 $109M 5.0M 21.83
2023-06-30 $154M 4.8M 31.79
2023-03-31 $109M 4.5M 24.39
2022-12-31 $141M 4.5M 31.54
2022-06-30 $109M 4.1M 26.45
2021-06-30 $68M 2.7M 25.60
2021-03-31 $15M 1.1M 13.89
2020-12-31 $18M 1.1M 16.81